The Australian medical community is abuzz with the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist showing significant results in early trials for managing obesity. This treatment https://worldlistpro.com/story23856363/the-new-retatrutide-australia-a-new-hope-for-weight-management